These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25 related articles for article (PubMed ID: 14059865)
1. [Proposal of a modification of the thromboelastographic method for the study of fibrinolysis activated with streptokinase]. CACCIOLA E; FICHERA C; FERRAUTO A Boll Soc Ital Biol Sper; 1960 Dec; 36():1307-10. PubMed ID: 13689689 [No Abstract] [Full Text] [Related]
2. [Experiences with therapeutic fibrinolysis by streptokinase]. FISCHBACHER W Schweiz Med Wochenschr; 1960 Oct; 90():1241-3. PubMed ID: 13699798 [No Abstract] [Full Text] [Related]
3. [Resistance index of fibrinolysis (RIF)]. Paleirac G; Kahn P Hemostase; 1965 Sep; 5(3):317-9. PubMed ID: 5856893 [No Abstract] [Full Text] [Related]
4. EFFECT OF STREPTOKINASE ON POSTOPERATIVE CHANGES IN SOME COAGULATION FACTORS AND THE FIBRINOLYTIC SYSTEM. OLOW B Acta Chir Scand; 1963 Sep; 126():197-210. PubMed ID: 14062916 [No Abstract] [Full Text] [Related]
5. Mechanism of thrombolysis. AMBRUS C Thromb Diath Haemorrh; 1961; 6(Suppl 1)():185-7. PubMed ID: 14012534 [No Abstract] [Full Text] [Related]
6. [Cryofibrinogenemia and pathologically increased fibrinolysis a patient with prostate cancer]. BOROS M; TARNOKY K; VERECZKEY C; RAK K Z Klin Med; 1962; 157():68-76. PubMed ID: 13871414 [No Abstract] [Full Text] [Related]
7. [Metastatic prostatic cancer with hemorrhagic diathesis due to fibrinolysis; case report]. RASMUSSEN J; SCHWARTZ M Ugeskr Laeger; 1957 Aug; 119(34):1086-90. PubMed ID: 13468146 [No Abstract] [Full Text] [Related]
9. [Severe hemorrhagic syndrome caused by fibrinolysis during metastatic prostate osteosis]. SERRE H; IZARN P; SIMONL Rev Rhum Mal Osteoartic; 1963; 30():32-6. PubMed ID: 13988148 [No Abstract] [Full Text] [Related]
10. [Cryofibrinogenemia and pathological increase in fibrolysis in prostatic carcinoma]. BOROS M; TARNOKY K; VERECZKEY C; RAK K Orv Hetil; 1963 Mar; 104():509-11. PubMed ID: 14014039 [No Abstract] [Full Text] [Related]
11. [CHRONIC FIBRINOLYSIS IN PROSTATIC CARCINOMA]. STOCKER H; MAIER C Schweiz Med Wochenschr; 1964 Sep; 94():1373-4. PubMed ID: 14323326 [No Abstract] [Full Text] [Related]
12. Fibrinolysis and fibrinogenemia in carcinoma of the lung. O'NEILL JJ; EVANS TS Conn Med; 1961 Mar; 25():158-61. PubMed ID: 13730105 [No Abstract] [Full Text] [Related]
13. The significance of fibrinolysis occurring in patients with metastatic cancer of the prostate. TAGNON HJ; WHITMORE WF; SCHULMAN P; KRAVITZ SC Cancer; 1953 Jan; 6(1):63-7. PubMed ID: 13009653 [No Abstract] [Full Text] [Related]
14. Fibrinolysis in metastatic cancer of the prostate. TAGNON HJ; WHITMORE WF; SHULMAN NR Cancer; 1952 Jan; 5(1):9-12. PubMed ID: 14886894 [No Abstract] [Full Text] [Related]
15. [The fibrinolytic enzyme system in the tissue of prostatic tumor]. KURODA K; HISAZUMI H; KORAI Y Nihon Hinyokika Gakkai Zasshi; 1962 Oct; 53():735-53. PubMed ID: 13927522 [No Abstract] [Full Text] [Related]
16. Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects. Schmitt M; Mengele K; Gkazepis A; Napieralski R; Magdolen V; Reuning U; Harbeck N Breast Care (Basel); 2008; 3(s2):3-10. PubMed ID: 20824007 [No Abstract] [Full Text] [Related]
17. FIBRINOLYSIS IN PATIENTS WITH PROSTATIC CANCER. ANDERSSON L Acta Chir Scand; 1963; 126():172-83. PubMed ID: 14059865 [No Abstract] [Full Text] [Related]
18. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD FOR OBTAINING A THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS. HELLE I Acta Med Scand; 1963 Sep; 174():271-9. PubMed ID: 14058752 [No Abstract] [Full Text] [Related]